Status:

COMPLETED

Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment

Lead Sponsor:

University of Jordan

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

PHASE2

Brief Summary

This study aims at expanding Umbilical Cord derived Mesenchymal Stem Cells (MSCs) to a clinical scale according to Good Laboratory Practice and study its efficacy when compared to a Supervised Physica...

Detailed Description

Umbilical cord derived MSCs bank will be generated and all patients given the same cells from the same biological sample. Thorough clinical, cognitive and motor analysis will be performed at baseline...

Eligibility Criteria

Inclusion

  • A clinical diagnosis of definite MS according to the revised McDonald Criteria.
  • Expanded Disability Status Scale (EDSS) ≤ 7
  • Failure of standard medical therapy
  • Disease duration of at least three years prior to enrollment.

Exclusion

  • Pregnant and lactating women
  • Previous treatment with immunosuppressive agents in the last 12 months prior to enrollment
  • Recent MS relapse in the month prior to enrollment
  • Treatment with oral or parenteral steroids for any cause in the month prior to enrollment
  • Significant systemic medical disorders including cardiac, renal, hepatic, hematologic, immunologic or endocrine disorders
  • Previous treatment with interferons or glatiramer acetate in the 3 months prior to enrollment
  • Any contra-indication for magnetic resonance imaging (MRI) or gadolinium contrast.
  • Positive serology for HIV, Hepatitis B or Hepatitis C
  • Any history of malignancy or exposure to radiation at any time prior to enrollment
  • Any contra-indication to lumbar puncture
  • Severe cognitive impairment that would interfere with the patient's ability to understand and sign the informed consent.

Key Trial Info

Start Date :

September 25 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 20 2020

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03326505

Start Date

September 25 2017

End Date

February 20 2020

Last Update

March 4 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Cell Therapy Center, University of Jordan

Amman, Jordan, 11942

2

Cell Therapy Center

Amman, Jordan, 11942